申请人:Agouron Pharmaceuticals, Inc.
公开号:US06548494B1
公开(公告)日:2003-04-15
Compounds of the formula shown below are poly(ADP-ribosyl)transferase inhibitors:
Such compounds are useful as therapeutics in treating cancers and in ameliorating the effects of stroke, head trauma, and neurodegenerative disease.
以下化学式显示的化合物是聚(ADP-核糖基)转移酶抑制剂:这些化合物在治疗癌症和改善中风、头部创伤和神经退行性疾病的疗效方面非常有用。